| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/09/2011 | CN101970415A 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
| 02/09/2011 | CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
| 02/09/2011 | CN101970411A (e) -n -(2-amino-phenyl) -3-{1-[4-(1-methyl-1h-pyrazol-4-yl)- benzenesulfonyl]-1h-pyrrol-3-yl} -acrylamide salts |
| 02/09/2011 | CN101970404A Novel method for the production of sulphonylpyrroles as hdac inhibitors |
| 02/09/2011 | CN101970006A Alpha 5 - beta 1 antibodies and their uses |
| 02/09/2011 | CN101970005A Breaking immunological tolerance with a genetically encoded unnatural amino acid |
| 02/09/2011 | CN101970004A Methods for using and identifying modulators of delta-like 4 |
| 02/09/2011 | CN101970003A Uses of anti-cd40 antibodies |
| 02/09/2011 | CN101969980A Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and/or their cancerous counterpart |
| 02/09/2011 | CN101969967A Agent for prevention of alcoholic hepatopathy |
| 02/09/2011 | CN101969963A Pharmaceutical composition and combined agent |
| 02/09/2011 | CN101969961A Cholestanol derivative for combined use |
| 02/09/2011 | CN101969954A Triarylmethane analogs and their use in treating cancers |
| 02/09/2011 | CN101969947A Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
| 02/09/2011 | CN101967495A Construction of C35 gene siRNA expression vector of breast cancer cell and antineoplastic therapy application |
| 02/09/2011 | CN101967202A Method for producing medicinal fungi polysaccharide with high anti-tumor activity |
| 02/09/2011 | CN101967196A Interferon fusion protein, preparation thereof and application thereof |
| 02/09/2011 | CN101967193A Hsp60 fragment capable of being combined with LOX-1, derivatives thereof and use thereof |
| 02/09/2011 | CN101967192A Fusion protein of anti-CD20 antibody fragment and lidamycin (LDM) as well as preparation method and application thereof |
| 02/09/2011 | CN101967191A Preparation method of HLA-G (Human Leukocyte Antigen G) antibody and application of HLA-G antibody in medicine |
| 02/09/2011 | CN101967173A Novel camptothecin derivative coupled with cholic acid at position 10 |
| 02/09/2011 | CN101967172A Novel derivates of camptothecin 10-position coupled bile acid |
| 02/09/2011 | CN101967168A Triterpenoid saponin derivative and preparation method and application thereof |
| 02/09/2011 | CN101967164A Ruthenium (II) complex, preparation method thereof and application thereof to preparation of antitumor medicaments |
| 02/09/2011 | CN101967163A Platinum (II) anti-cancer compound with selectivity for cancer cells |
| 02/09/2011 | CN101967154A Oxime compounds, preparation method and application thereof |
| 02/09/2011 | CN101967152A New methylenedioxy xanthone compound and anti-tumor effect thereof |
| 02/09/2011 | CN101967150A Spiroheterocyclic compounds and their uses as therapeutic agents |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101967144A Phenanthroline derivative and preparation method and application thereof |
| 02/09/2011 | CN101967142A Thiazoleamide compound and medical application thereof in treating malignant tumor |
| 02/09/2011 | CN101967140A Deuterated crizotinib as well as derivant, preparation method and application thereof |
| 02/09/2011 | CN101967138A Fatty acid schisantherin A ester compound |
| 02/09/2011 | CN101967135A 4-aryl coumarin compound and preparation method and application thereof |
| 02/09/2011 | CN101967127A Quinazoline derivative and preparation method thereof and application of quinazoline derivative for preparing anticancer drugs |
| 02/09/2011 | CN101967125A Hsp90 inhibitor Xbj-B16-1 and preparation method and application thereof |
| 02/09/2011 | CN101967113A 3-alloc amido-3-(3- nitryl-4-fluorophenyl) propionic acid and preparation method thereof |
| 02/09/2011 | CN101967105A Beta-hydroxy protected didecyl quaternary ammonium salt with anticancer activity and preparation method thereof |
| 02/09/2011 | CN101967094A Phenylacetyl quinic acid of witlooves and ester compound thereof |
| 02/09/2011 | CN101966338A Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist |
| 02/09/2011 | CN101966337A Genetic products differentially expressed in tumors and the use thereof |
| 02/09/2011 | CN101966335A Novel HER2/neu gene-modified dendritic cell vaccine |
| 02/09/2011 | CN101966332A Application of gap junction protein and coding gene thereof in preparing medicament for reversing malignant phenotype of cancer stem cell |
| 02/09/2011 | CN101966322A Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof |
| 02/09/2011 | CN101966321A Traditional Chinese medicinal composition for treating breast cancer and preparation method thereof |
| 02/09/2011 | CN101966310A Traditional Chinese medicine for treating lung cancer |
| 02/09/2011 | CN101966292A Sugarless Chinese medicinal oral liquid and preparation method thereof |
| 02/09/2011 | CN101966272A Chinese medicinal composition for treating proliferative diseases |
| 02/09/2011 | CN101966255A Chinese medicinal composition for treating mammary gland hyperplasia and breast cancer and preparation method thereof |
| 02/09/2011 | CN101966221A Application of prickly pear in preparation of medicaments or health-care products |
| 02/09/2011 | CN101966211A Application of dolichandrone cauda-felina in preparation of medicament for treating tumors |
| 02/09/2011 | CN101966207A Preparation method and content measuring method of macrothelypteris viridifrons total flavone with anti-tumor activity |
| 02/09/2011 | CN101966199A Application of campanumoea polysaccharide in preparation of medicament and health care food |
| 02/09/2011 | CN101966179A Anti-tumor epothilone oral liquid |
| 02/09/2011 | CN101966177A Application of imperatorin in preparing antineoplastic drugs with multi-drug resistance (MDR) |
| 02/09/2011 | CN101966158A Bendamustine hydrochloride freeze-dried powder injection for injection and preparation method thereof |
| 02/09/2011 | CN101966157A Decitabine sustained release microsphere and preparation method thereof |
| 02/09/2011 | CN101966153A Preparation process of As2O3/Fe3O4 composite nano-particles |
| 02/09/2011 | CN101965974A Compositions and products containing enantiomeric equol, and methods for their making |
| 02/09/2011 | CN101647773B Octreotide acetate injection |
| 02/09/2011 | CN101538537B Pestalotiopsis fici, and discovery and application of Pestalotiopsis fici generated anti-tumor active compounds thereof |
| 02/09/2011 | CN101518633B Traditional Chinese medicine for treating thyroid cancer |
| 02/09/2011 | CN101468974B Semi-synthesizing method for polyenic taxusol |
| 02/09/2011 | CN101463037B Method for synthesizing taspine |
| 02/09/2011 | CN101411879B SiO2/Au nano material with nucleocapsid structure-biological protein medicament complex and preparation method thereof |
| 02/09/2011 | CN101352573B Recombinant human granulocyte colony stimulating factor lysine defect body modified by polyethyleneglycol |
| 02/09/2011 | CN101347425B Uses of ampelopsin and total flavone valid target rich in ampelopsin in preparing medicament for preventing and treating prostate gland cancer |
| 02/09/2011 | CN101337957B Scutellarin derivates, preparation method and application thereof |
| 02/09/2011 | CN101289453B Ellagic acid compounds preparation method |
| 02/09/2011 | CN101273989B Berbamine derivative and application of salt thereof |
| 02/09/2011 | CN101272766B Composition for administration to mammals or humans |
| 02/09/2011 | CN101181315B New purpose of Yulangsan polysaccharide |
| 02/09/2011 | CN101117349B A macrocyclic oxidation substituted pentacyclic triterpanoids derivative and preparation method and use thereof |
| 02/09/2011 | CN101108846B 4- fragrant amido quinazoline derivatives and method of manufacturing the same and application in pharmacy thereof |
| 02/09/2011 | CN101107261B Imidazopyridine derivative |
| 02/09/2011 | CN101095672B Novel pharmacy use of medicinal composition |
| 02/09/2011 | CN101070538B Human epiterm growth-factor receptor mutation gene and use thereof |
| 02/09/2011 | CN101068810B Carbostyril compound |
| 02/09/2011 | CN101036638B Application of glycyrrhizin in the preparation of medicine for preventing and curing tumour |
| 02/09/2011 | CN101020044B Regulating and controlling effect of thymine DNA glycosylase on signal transducing path |
| 02/08/2011 | USRE42132 have special action with respect to tubulin polymerization inhibition and can be used for treating prostate cancer, breast cancer, colon cancer, non-small-cell-lung cancer, or primary dermal microvascular endothelial cell proliferation; 2-methoxy-17a-oxo-17a-homoestra-1,3,5(10)-trien-3-yl sulfamate |
| 02/08/2011 | US7884204 Phenylalanine derivatives |
| 02/08/2011 | US7884183 Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
| 02/08/2011 | US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 02/08/2011 | US7884109 immunosuppressants such as 2-(6-Fluoro-1H-benzo[d]imidazol-1-yl)-9-((1R,4R)-4-hydroxy-1,2,3,4-tetrahydronaphthalen-1-yl)-7H-purin-8(9H)-one, used for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection |
| 02/08/2011 | US7884092 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/08/2011 | US7884082 Combined therapeutical treatment of hyperproliferative diseases |
| 02/08/2011 | US7883896 for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as lung adenocarcinoma, lung carcinoma |
| 02/08/2011 | US7883889 Using 5-aza-cytidine or 5-aza-2'-deoxycytidine to hypomethylate cells expressing tumor associated antigens; immunotherapy; genetic vaccines and the diagnosis, prevention and treatment of cancer |
| 02/08/2011 | US7883880 DNA polymerase lambda and uses thereof |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/08/2011 | CA2615991C Substituted propanamide derivative and pharmaceutical composition comprising the same |
| 02/08/2011 | CA2562951C Indene derivatives and process for the preparation thereof |
| 02/08/2011 | CA2494300C Growth hormone releasing peptides |
| 02/08/2011 | CA2480940C Non-steroidal progesterone receptor modulators |
| 02/08/2011 | CA2479906C Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 02/08/2011 | CA2478068C Dihydropyrazole compounds useful for treating or preventing cancer |
| 02/08/2011 | CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |